Sichuan Goldstone Asia Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Sichuan Goldstone Asia Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥25.0M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥2.8B and CN¥391.5M respectively. Sichuan Goldstone Asia Pharmaceutical's EBIT is CN¥107.8M making its interest coverage ratio -9.4. It has cash and short-term investments of CN¥504.0M.
Key information
1.0%
Debt to equity ratio
CN¥25.03m
Debt
| Interest coverage ratio | -9.4x |
| Cash | CN¥504.02m |
| Equity | CN¥2.42b |
| Total liabilities | CN¥391.53m |
| Total assets | CN¥2.81b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 300434's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥320.0M).
Long Term Liabilities: 300434's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥71.5M).
Debt to Equity History and Analysis
Debt Level: 300434 has more cash than its total debt.
Reducing Debt: 300434's debt to equity ratio has increased from 0.4% to 1% over the past 5 years.
Debt Coverage: 300434's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 300434 earns more interest than it pays, so coverage of interest payments is not a concern.